Coverage
-
October 18, 2011
A New York federal judge on Tuesday tossed a shareholder class action alleging biotechnology company Elan Corp. PLC failed to disclose that a proposed $1 billion deal with Johnson & Johnson violated an agreement with Biogen Idec Inc.
1 other articles on this case.
View all »